Summary
Within the realm of cancer outcomes, structural racism assumes a critical role as it encompasses the interplay of systems, structures, and institutions that maintain and perpetuate cancer care inequities
This research aimed to investigate the associations between structural racism and treatment initiation as well as survival rates among individuals diagnosed with four specific types of solid-tumor cancers: metastatic breast cancer (mBC), advanced non-small cell lung cancer (aNSCLC), metastatic pancreatic cancer (mPC), and advanced endometrial cancer (aEC).
Why this matters
By exploring these associations, this study aims to shed light on the contribution of structural racism to inequities in cancer care delivery and outcomes.